Clinical Practice Guidelines Antenatal Care — Module II

9.11References

Alanen A, Kahala K, Vahlberg T et al (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 112(1): 50–56.

Bjerke SEY, Vangen S, Holter E et al (2011) Infectious immune status in an obstetric population of Pakistani immigrants in Norway. Scand J Pub Health 39(5): 464–70.

Burny W, Liesnard C, Donner C et al (2004) Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection. Exp Rev Anti-Infect Ther 2(6): 881–94.

Buxman H, Von Stackelberg OM, Schloesser RL et al (2012) Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 40(4): 440–46.

Cahill A, Odibo A, Stamilio D et al (2009) Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 201(5): 466.

Cannon MJ, Westbrook K, Levis D et al (2012) Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Prevent Med 54(5): 351–57.

CDC (2008) Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy -- United States, 2007. Centre for Disease Control and Prevention. MMWR 57(3): 65–68.

Coll O, Benoist G, Ville Y et al (2009) Guidelines on CMV congenital infection. J Perinat Med 37(5): 433–45.

Cordier AG, Guitton S, Vauloup-Fellous C et al (2012) Awareness of cytomegalovirus infection among pregnant women in France. J Clin Virol 53(4): 332–37.

De Paschale M, Agrappi C, Manco M et al (2010) Positive predictive value of anti-HCMV IgM as an index of primary infection. J Virol Methods 168(1-2): 121–25.

Demmler G (2005) Screening for congenital cytomegalovirus infection: a tapestry of controversies. J Paediatr 146: 162–64.

DeVries J (2007) The ABCs of CMV. Advance Neonat Care 7(5): 248–55.

Dollard S, Grosse S, Ross D (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5): 355–63.

Enders G, Daiminger A, Baeder U et al (2012b) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52(3): 244–46.

Enders G, Daiminger A, Baeder U et al (2013) The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. J Clin Virol 56(2): 102–07.

Enders G, Daiminger A, Lindemann L et al (2012a) Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010. Med Microbiol Immunol 201(3) :303–09.

ECCI (2006) European Congenital Cytomegalovirus Initiative Recommendations. Accessed 22 February 2012.

Feldman, B, Yinon Y, Tepperberg Oikawa M et al (2011) Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynaecol 52(3): 244–46.

Fowler K, Stagno S, Pass R (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289(8): 1008–11.

Gabbay-Ben Ziv R, Yogev, Y, Peled Y et al (2012) Congenital cytomegalovirus infection following antenatal negative diagnostic amniotic fluid analysis-A single center experience. J Maternal-Fetal Neonat Med 25(9): 1787–90.

Gaytant M, Galama J, Semmekrot B et al (2005) The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 76(1): 71–75.

Gilbert GL (2002) 1. Infections in pregnant women. Med J Aust 176: 229–36.

Gindes L, Teperberg-Oikawa M, Sherman D et al (2008) Congenital cytomegalovirus infection following primary maternal infection in the third trimester. BJOG 115(7): 830–35.

Goncé A, Marcos MA, Borrell A et al (2012) Maternal IgM antibody status in confirmed fetal cytomegalovirus infection detected by sonographic signs. Prenat Diag 32(9): 817–21.

Harvey J & Dennis C (2008) Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review. J Adv Nurs 63(5): 440–50.

Hyde T, Schmid D, Cannon M (2010) Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 20(5): 311–26.

Jiang H, Chen S, Wen L (2006) Effects of Jinye Baidu Granule on fetal growth and development with maternal active human cytomegalovirus infection. Chin J Integrative Med 12(4): 250–54.

Kenneson A & Cannon M (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4): 253–76.

Khare M, Sharland M, Manyonda I et al (2004) Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative women. J Virol Methods 19: 31–35.

Lazzarotto T, Guerra B, Gabrielli L et al (2011) Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 17(9): 1285–93.

Leung, A, Sauve R, Davies H (2003) Congenital cytomegalovirus infection. J Nat Med Assoc 95(3): 213–18.

McCarthy F, Giles M, Rowlands S et al (2011) Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Of Systematic Reviews.

Naessens A, Casteels A, Decatte L et al (2005) A serologic strategy for detecting neonates at risk for congenital cytomegalovirus infection. J Paediatr 146(2): 194–97.

NHMRC (2013) Staying Healthy in Child Care Preventing Infectious Diseases in Child Care. 5th edition. Commonwealth of Australia.

Nigro G & Adler S(2011) Cytomegalovirus infections during pregnancy. Curr Op Obstet Gynecol 23(2): 123–28.

Nigro G, Adler S, La Torre R et al (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. New Engl J Med 353(13): 1350–62.

Nigro G, Adler SP, Parruti G et al (2012) Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy – a case control study of the outcome in children. J Infect Dis 205(2): 215–27.

Nyholm J & Schleiss M (2010) Prevention of maternal cytomegalovirus infection: Current status and future prospects. Int J Women's Health 2(1): 23–35.

Ornoy A (2007) Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: are we close to prevention? Israel Med Assoc J 9(5): 398–401.

Ornoy A & Diav-Citrin O (2006) Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 21(4): 399–409.

Parmigiani S, Barini R, Costa S et al (2003) Accuracy of the serological ELISA test compared with the polymerase chain reaction for the diagnosis of cytomegalovirus infection in pregnancy. Sao Paulo Med J 121(3): 97–101.

Peled Y, Yogev Y, Oron G et al (2011) Suggested algorithm for cytomegalovirus surveillance in low-risk pregnancies. J Maternal-Fetal Neonat Med 24(11): 1353–56.

Picone O, Vauloup-Fellous C, Cordier A et al (2009) A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 116: 818–23.

Polilli E, Parruti G, D'Arcangelo F et al (2012) Preliminary evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women with Primary Cytomegalovirus Infection. Clin Vaccine Immunol 19(12):1991–93.

Ridley G, Zurynski Y, Elliot E (2008) Australian Paediatric Surveillance Unit Research Report 2007–2008. Sydney: Australian Paediatric Surveillance Unit.

Ross D, Victor M, Sumartojo E et al (2008) Women's knowledge of congenital cytomegalovirus: Results from the 2005 Healthstyles survey. J Women’s Health 17(5): 849–58.

Schlesinger Y, Halle D, Eidelman A et al (2003) Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child 88(5): F371–74.

Sonoyama A, Ebina Y, Morioka I et al (2012) Low IgG Avidity and Ultrasound Fetal Abnormality predict Congenital Cytomegalovirus Infection. J Med Virol 84(12): 1928–33.

Tagawa M, Minematsu T, Masuzaki H et al (2010) Seroepidemiological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan. Pediatr Int 52(3): 459–62.

Uysal A, Taner CE, Cuce M et al (2012) Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet 286(3): 605–08.

Vauloup-Fellous C, Picone O, Cordier A-G et al (2009) Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 46(4): S49–53.

Visentin S, Manara R, Milanese L et al (2012) Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year age. Clin Infect Dis 55(4): 497–503.

Yamada H, Morizane M, Tanimura K et al (Japanese Congenital Cytomegalovirus Infection immunoglobulin Fetal Therapy Study Group) (2012) A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J Reprod Immunol 95(1-2): 73–79.